NRT about doubles the quit rates of behavioral interventions alone Nicotine replacement therapy: What are the options today?

Stephen I. Rennard

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Four formulations of nicotine replacement therapy (NRT) have been approved by the PDA-the patch, gum, a nasal spray, and an inhaler. The goal when administering NRT is to prevent the onset of withdrawal symptoms and reduce nicotine cravings. The ideal dosage of NRT provides nicotine below the level absorbed while smoking, thereby discouraging the addiction that had been caused by smoking. NRT significantly improves smoking quit rates and therefore merits consideration in all patients attempting to quit, including most of those with coronary artery disease. The nicotine patch provides a steady serum level of nicotine. The other formulations can be given along with the patch for use when the craving is strong or withdrawal symptoms are troublesome.

Original languageEnglish (US)
Pages (from-to)S20-S25
JournalJournal of Respiratory Diseases
Volume19
Issue number8 SUPPL.
StatePublished - 1998

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'NRT about doubles the quit rates of behavioral interventions alone Nicotine replacement therapy: What are the options today?'. Together they form a unique fingerprint.

Cite this